申请人:The DuPont Merck Pharmaceutical Co.
公开号:US05296478A1
公开(公告)日:1994-03-22
Compounds of Formula I have been shown to enhance the release of the neurotransmitter acetlcholine, and thus may be useful as chemical intermediates and as pharmacological agents in the treatment of diseases of man, such as in Alzheimer's Disease and other conditions involving learning and cognition, where subnormal levels of this neurochemical are found. ##STR1##
已经证明,具有I式化合物的物质能够增强神经递质乙酰胆碱的释放,因此可能有用作化学中间体和药理剂,用于治疗人类疾病,如阿尔茨海默病和其他涉及学习和认知的疾病,这些疾病中存在乙酰胆碱水平低下的情况。